Potential Resistance By Cancer Cells For Multi-Drugs - Daniel, Esther Priyadharshini;Tabbasum M. D., Tameem
36,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Cancer is a dreadful disease in which the abnormal cells proliferate without control and invade other parts of the body resulting in tumour. Causes for cancer includes tobacco use, excess body weight, inherited genetic mutations, hormones, immune condition, etc. According to the World Health Organization's (WHO) finding, it is expected that annual cancer cases will rise from 14 million in 2012 to 22 within the next two decades. This is a real alarm to the society and gives us a challenging opportunity to break the threat. Despite having treatment for cancer the rate of success is less. The…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Cancer is a dreadful disease in which the abnormal cells proliferate without control and invade other parts of the body resulting in tumour. Causes for cancer includes tobacco use, excess body weight, inherited genetic mutations, hormones, immune condition, etc. According to the World Health Organization's (WHO) finding, it is expected that annual cancer cases will rise from 14 million in 2012 to 22 within the next two decades. This is a real alarm to the society and gives us a challenging opportunity to break the threat. Despite having treatment for cancer the rate of success is less. The reason is the cancer cells develop resistance for the treatment and regenerate their properties. Therefore this book provides information regarding their resistance for the treatment along with data about few types of cancers and their strategies to overcome treatment. Different types of transporters which are responsible for the resistance of cancer cells during treatment are mentioned. Few are ABC transporters, P-gp, Pten etc. Many drugs with capacity to overcome resistance are listed and included. Cancer cells adapt instantly for every condition and strategies of cancer cells are discussed.
Autorenporträt
Dr. Esther Priyadharshini hat 2016 und 2008 an der VIT-Universität in Indien einen Doktortitel und einen Master of Science in Biomedizinischer Genetik erworben. Ihre derzeitigen Forschungsinteressen liegen in den Bereichen Krebsbiologie, Antibiotikaresistenz und ESBL-produzierende Bakterien.